Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice
- PMID: 9114056
- PMCID: PMC20789
- DOI: 10.1073/pnas.94.9.4710
Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice
Abstract
To overcome the genetic and interindividual variability frequently noted in complex phenotypes, we used echocardiographic selection to develop a substrain of myosin light chain (MLC)-Ras (RAS) transgenic mice with an enhanced ventricular hypertrophic phenotype. These echo-selected mice were then compared with wild-type (WT) animals and a pressure overload hypertrophy model (transverse aortic constriction; TAC). Echocardiography demonstrated increased wall thickness in RAS compared with the other groups. We developed novel miniaturized physiological technology to quantitatively identify in vivo intraventricular gradients; increased systolic Doppler velocity was seen in the left ventricle (LV) in 69% of RAS vs. none of WT or TAC. Intracavitary pressure gradients were present in 3 of 10 RAS vs. none of TAC or WT. Passive diastolic LV stiffness was not different among the three groups. Myofibrillar disarray was present in all RAS animals and was significantly more extensive (21.7% area fraction) than in TAC (1.5%) or WT (0.0%). RAS mice had selective induction of natriuretic peptide genes in the LV, a pattern distinct from that induced by pressure overload. Juvenile mortality was significantly increased in the offspring of echo-selected RAS parents. We conclude that adaptation of echocardiography to the mouse permits selection for cardiac phenotypes, and that selectively inbred MLC-Ras transgenic mice faithfully reproduce the molecular, physiological, and pathological features of human hypertrophic cardiomyopathy (HCM). Because previous studies support the concept that hypertrophy in human HCM is secondary to dysfunction created by sarcomeric protein mutations, the current studies suggest that Ras-dependent pathways might play a similar role in forms of human HCM.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/20789/bin/pq0970641001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/20789/bin/pq0970641002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/20789/bin/pq0970641003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/20789/bin/pq0970641004.gif)
Similar articles
-
Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H552-H562. doi: 10.1152/ajpheart.00212.2017. Epub 2017 Dec 1. Am J Physiol Heart Circ Physiol. 2018. PMID: 29196344
-
Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.J Mol Cell Cardiol. 2004 Nov;37(5):979-87. doi: 10.1016/j.yjmcc.2004.07.010. J Mol Cell Cardiol. 2004. PMID: 15522275
-
Pregnancy mitigates cardiac pathology in a mouse model of left ventricular pressure overload.Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H807-14. doi: 10.1152/ajpheart.00056.2016. Epub 2016 Jul 1. Am J Physiol Heart Circ Physiol. 2016. PMID: 27371681
-
Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.Cardiovasc Res. 2008 Apr 1;78(1):79-89. doi: 10.1093/cvr/cvn001. Epub 2008 Jan 10. Cardiovasc Res. 2008. PMID: 18187461
-
Induction and analysis of cardiac hypertrophy in transgenic animal models.Methods Mol Med. 2005;112:339-52. doi: 10.1385/1-59259-879-x:339. Methods Mol Med. 2005. PMID: 16010028 Review.
Cited by
-
Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling.Circ Genom Precis Med. 2022 Dec;15(6):e003546. doi: 10.1161/CIRCGEN.121.003546. Epub 2022 Oct 11. Circ Genom Precis Med. 2022. PMID: 36252118 Free PMC article.
-
HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models.J Clin Invest. 2022 Apr 15;132(8):e131053. doi: 10.1172/JCI131053. J Clin Invest. 2022. PMID: 35230976 Free PMC article.
-
Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies.Biol Res. 2021 Aug 3;54(1):23. doi: 10.1186/s40659-021-00342-6. Biol Res. 2021. PMID: 34344467 Free PMC article. Review.
-
Network-based predictions of in vivo cardiac hypertrophy.J Mol Cell Cardiol. 2018 Aug;121:180-189. doi: 10.1016/j.yjmcc.2018.07.243. Epub 2018 Jul 17. J Mol Cell Cardiol. 2018. PMID: 30030017 Free PMC article.
-
Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.Mol Cell Biochem. 2017 Jan;424(1-2):123-145. doi: 10.1007/s11010-016-2849-0. Epub 2016 Oct 20. Mol Cell Biochem. 2017. PMID: 27766529 Free PMC article. Review.
References
-
- Hunter J J, Tanaka N, Rockman H A, Ross J, Chien K R. J Biol Chem. 1995;270:23173–23178. - PubMed
-
- Tanaka N, Dalton N, Mao L, Rockman H A, Peterson K L, Gottshall K R, Hunter J J, Chien K R, Ross J., Jr Circulation. 1996;94:1109–1117. - PubMed
-
- Rockman, H. A., Knowlton, K. U., Ross, J., Jr., Chien, K. R. (1993) Circulation 87, Suppl VII, VII-1–VII-21.
-
- Omens J H, Rockman H A, Covell J W. Am J Physiol. 1994;266:H1169–H1176. - PubMed
-
- Mirsky I. Circulation. 1984;69:836–841. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources